Tipranavir: A Ritonavir-Boosted Protease InhibitorA Viewpoint by Dushyantha T. Jayaweera

被引：0
|
作者：
Dushyantha T. Jayaweera
机构：
[1] University of Miami,Division of Infectious Diseases, Department of Medicine
来源：
Drugs | 2005年 / 65卷
关键词：
Ritonavir; Salvage Therapy; Gastrointestinal Toxicity; Lopinavir; Pivotal Study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1678 / 1679
页数：1
相关论文
共 50 条
  • [31] Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy
    Brayer, Samuel W.
    Reddy, K. Rajender
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) : 547 - 558
  • [32] The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors
    Fox, Zoe V.
    Geretti, Anna Maria
    Kjaer, Jesper
    Dragsted, Ulrik Bak
    Phillips, Andrew N.
    Gerstoft, Jan
    Staszewski, Schlomo
    Clotet, Bonaventura
    von Wyl, Viktor
    Lundgren, Jens D.
    AIDS, 2007, 21 (15) : 2033 - 2042
  • [33] Simplifying the treatment of HIV infection with ritonavir-boosted protease inhibitors in antiretroviral-experienced patients
    Scott, JD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (08) : 809 - 815
  • [34] Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
    Zeldin, RK
    Petruschke, RA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 4 - 9
  • [35] Iatrogenic Hypercortisolism Complicating Triamcinolone Acetonide Injections in Patients with HIV on Ritonavir-Boosted Protease Inhibitors
    Fessler, David
    Beach, Jennifer
    Keel, John
    Stead, Wendy
    PAIN PHYSICIAN, 2012, 15 (06) : 489 - 493
  • [36] Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
    Martinez, Esteban
    Larrousse, Maria
    Llibre, Josep M.
    Gutierrez, Felix
    Saumoy, Maria
    Antela, Antonio
    Knobel, Hernando
    Murillas, Javier
    Berenguer, Juan
    Pich, Judit
    Perez, Ignacio
    Gatell, Jose M.
    AIDS, 2010, 24 (11) : 1697 - 1707
  • [37] Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR
    Wyatt, Christina M.
    Chaudhari, Juhi
    Miao, Shiyuan
    Krishnasami, Zipporah
    Hellinger, James
    Levey, Andrew S.
    Ross, Michael
    Ryom, Lene
    Mocroft, Amanda
    Brunet, Laurence
    Fusco, Jennifer
    Inker, Lesley A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (05): : 734 - 737
  • [38] Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran
    Kakadiya, Payal P.
    Higginson, Robert T.
    Fulco, Patricia Pecora
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)
  • [39] Sildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease Inhibitors
    Chinello, Pierangelo
    Cicalini, Stefania
    Pichini, Simona
    Pacifici, Roberta
    Tempestilli, Massimo
    Petrosillo, Nicola
    CURRENT HIV RESEARCH, 2012, 10 (02) : 162 - 164
  • [40] Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression
    Hung, Tung-Che
    Chen, Guan-Jhou
    Cheng, Shu-Hsing
    Chen, Jhen-Hong
    Wei, Jheng-Lun
    Cheng, Chien-Yu
    Hung, Chien-Ching
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (06) : 865 - 871
12345